Cargando…

Retraction Note: Expression of Functional Anti-p24 scFv 183-H12-5C in HEK293T and Jurkat T Cells

Detalles Bibliográficos
Autor principal:	Omar, Mohammad Tasyriq Che
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2018
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311636/ https://www.ncbi.nlm.nih.gov/pubmed/30607346 http://dx.doi.org/10.15171/apb.2018.082

Ejemplares similares

Expression of Functional Anti-p24 scFv 183-H12-5C in HEK293T and Jurkat T Cells
por: Che Omar, Mohammad Tasyriq
Publicado: (2017)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cells
por: Tragoolpua, Khajornsak, et al.
Publicado: (2008)

A recombinant scFv-FasL(ext) as a targeting cytotoxic agent against human Jurkat-Ras cancer
por: Chan, Derek V, et al.
Publicado: (2013)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Retracted: In Vitro Evaluation of Cytotoxic Potential of Caladium lindenii Extracts on Human Hepatocarcinoma HepG2 and Normal HEK293T Cell Lines
por: International, BioMed Research
Publicado: (2023)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
por: Shriver-Lake, Lisa C., et al.
Publicado: (2016)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021)

Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas
por: Kim, D-J, et al.
Publicado: (2002)

Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein
por: Aavula, Shukra M., et al.
Publicado: (2011)

Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology
por: Sato, Mitsuru, et al.
Publicado: (2012)

Early Detection of NSCLC with scFv Selected against IgM Autoantibody
por: Pedchenko, Tetyana, et al.
Publicado: (2013)

Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
por: Alric, Christophe, et al.
Publicado: (2018)

Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms
por: Lu, Zhongpeng, et al.
Publicado: (2019)

Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018)

Development and in vitro characterization of a humanized scFv against fungal infections
por: Di Mambro, Tomas, et al.
Publicado: (2022)

Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies
por: Gupta, Vijay, et al.
Publicado: (2020)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
por: Bhatta, Pallavi, et al.
Publicado: (2018)

Bioinformatics in molecular immunology laboratories demonstrated: Modeling an anti-CMV scFv antibody
por: Heng, Chua Kek, et al.
Publicado: (2006)

Bacterial secretion of soluble and functional trivalent scFv-based N-terminal trimerbodies
por: Blanco-Toribio, Ana, et al.
Publicado: (2015)

Refolded scFv Antibody Fragment against Myoglobin Shows Rapid Reaction Kinetics
por: Song, Hyung-Nam, et al.
Publicado: (2014)

Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
por: Stech, Marlitt, et al.
Publicado: (2014)

A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity
por: Bai, Xuelian, et al.
Publicado: (2015)

Generation and characterization of a novel recombinant scFv antibody specific for Campylobacter jejuni
por: Nzuma, Ruramayi M., et al.
Publicado: (2018)

Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV
por: Zhao, Aizhi, et al.
Publicado: (2007)

Preparation of scFv stabilized chromatosomes for single-particle cryo-EM structure determination
por: Zhou, Bing-Rui, et al.
Publicado: (2021)

Anti-Idiotype scFv Localizes an Autoepitope in the Globular Domain of C1q
por: Todorova, Nadezhda, et al.
Publicado: (2021)

Preparation and Directed Evolution of Anti-Ciprofloxacin ScFv for Immunoassay in Animal-Derived Food
por: Wang, Fangyu, et al.
Publicado: (2021)

Generation and evaluation of IgY-scFv based mimetics against canine parvovirus
por: Ge, Shikun, et al.
Publicado: (2021)

Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv
por: Arslan, Merve, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4lckn42tfjih5mfnodrvo675s8